1 / 19

Peripheral Nerve Sheath Tumor Accession # 108167

James Montgomery, DVM December 29, 2008. Peripheral Nerve Sheath Tumor Accession # 108167. Accession # 108167. Boomer 9 year old, MC, Portuguese water dog 11 month history of left front lameness Intermittent non-weight bearing Non-responsive to NSAIDs or acupuncture

emelda
Download Presentation

Peripheral Nerve Sheath Tumor Accession # 108167

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. James Montgomery, DVM December 29, 2008 Peripheral Nerve Sheath Tumor Accession # 108167

  2. Accession # 108167 • Boomer • 9 year old, MC, Portuguese water dog • 11 month history of left front lameness • Intermittent non-weight bearing • Non-responsive to NSAIDs or acupuncture • Survey radiographs – WNL • Left shoulder arthrogram (Acc #107751) - WNL

  3. Biceps brachii tendon is smooth and regularly marginated.  No filling defects are identified within the joint space. The infraspinatus tendon is also outlined by contrast medium; it appears smoothly marginated.  Left shoulder arthrogramAccession # 107751

  4. MRIAccession # 108167 • 1 cm tubular mass caudomedial to the left shoulder joint • Extends dorsomedially and appears contiguous with thickened 7th and 8th cervical spinal nerves • Apparent extension into the vertebral canal on the left at C7 – T1 • Findings consistent with malignant peripheral nerve sheath tumor

  5. Malignant Peripheral Nerve Sheath Tumor • Have been referred to as schwannomas, neurinomas, neurilemmomas, neurofibromas, and neurofibromas • Most canine PNST are poorly differentiated • Cell origin is difficult to identify • May arise from any peripheral nerve • 80% - brachial plexus or its nerve roots • 20% - pelvic plexus, thoracolumbar nerve roots, and cranial nerves (trigeminal most commonly affected CN)

  6. Malignant Peripheral Nerve Sheath Tumor • Typically slow growing • Extend by local invasion along peripheral nerve roots and its branches • Rarely invade surrounding tissues • Metastasis rare • Neurologic signs due to compression of peripheral axons, spinal cord, or brain stem

  7. Malignant Peripheral Nerve Sheath Tumor • Signalment: • Mature dogs, rarely seen in cats • No breed or sex predilection • Clinical signs: • Chronic, progressive forelimb lameness • Muscle atrophy • Pain in the axillary area • Palpable mass • Horner’s syndrome, with loss of ipsilateral panniculus – loss of the first 2 thoracic nerve roots (contain preganglionic sympathetic fibers supplying the face, and give rise to the lateral thoracic nerve)

  8. Malignant Peripheral Nerve Sheath Tumor • Clinical signs continued: • LMN signs to affected limb • May be hemiparetic • Early signs very much like orthopedic disease • Differentiating between orthopedic and neurologic disease can be difficult • May result in a long period before a diagnosis is made • Between 4.8 and 6.1 months in one report

  9. Malignant Peripheral Nerve Sheath Tumor • Imaging • Survey radiographs – usually normal • Rule out orthopedic disease • May show enlarged intervertebral foramen or occasionally vertebral body lysis • Myelography • May see intradural extramedullary mass if nerve roots have been invaded • Ultrasound • Good screening tool but lack of tumor identification doesn’t rule out presence of a tumor • With severe muscle atrophy and no orthopedic disease, CT or MRI should be performed

  10. Ultrasound • Hypoechoic tubular axillary mass with no blood flow • Limitations • Difficulty in detecting extent of tumor • Measurements do not correlate with size of tumor • Axillary lymph nodes – false positive diagnosis

  11. CT • Rim enhancement noted frequently, often with central hypoattenuating areas • Masses as small as 1.0 cm can be identified on contrast enhanced scans • Smaller mass-like lesions may not be specifically associated with neuronal structures

  12. CT • Relies on noticeable soft tissue asymmetry or contrast enhancement • Can be difficult to assess nerve structures oriented obliquely to the transverse plane • MRI superior to CT for detecting brachial plexus tumors • Excellent contrast resolution • Able to distinguish nerve bundles from vessels

  13. MRI – Kraft, et al. 2007 • Majority – hyperintense to muscle on T2W images and isointense on T1W images • Most only minimally or heterogeneously contrast enhancing • Contrast enhancement critical to detecting subtle diffuse nerve sheath involvement or small isointense nodules • Transverse plane images including both axillae and the vertebral canal allow in-slice comparison to detect lesions by asymmetry

  14. MRI – Kraft, et al. 2007 • Higher resolution, smaller field of view, multiplaner examination of the cervicothoracic spine important for appreciating nerve root and foraminal involvement • Findings: • ~1/2 had diffuse thickening of brachial plexus nerves (smooth or nodular) • ~3/4 with diffuse thickening had extension into the vertebral canal

  15. MRI – Kraft, et al. 2007 • Findings (continued): • Nerve root thickening associated with widening of the intervertebral foramen • Contrast enhancement was only mild to moderate, and usually non-uniform • Ipsilateral muscle atrophy with hyperintense muscle bundles – T2, STIR, and pre-contrast T1 • Neurogenic atrophy, edema, fatty infiltrate, and fibrosis

  16. MRI – Kraft, et al. 2007 • Transverse precontrast (A) and postcontrast (B) T1-weighted images • Mass is isointense to muscle, and is identifiable by absence of a similar structure in slice images of the contralateralaxilla. • Postcontrast -minimal heterogeneous contrast enhancement

  17. MRI – Kraft, et al. 2007 • PD sequences did not provide unique info • T2W – lesions hyperintense to muscle but less intense than axillary fat • T2W – STIR – suppresses fat making hyperintense neoplastic lesions more noticeable • Small or diffuse lesions particularly difficult to see due to similar intensity to fat on T2W images, and to muscle on T1W images (pre-contrast) • As with people, visible contrast enhancement on T1W images is critical to detecting canine peripheral nerve sheath tumors

  18. Treatment and outcome • Early diagnosis and surgical removal key to good outcome • Canine PNST have a more infiltrative and malignant behavior than the human counterpart • Tumor margins difficult to identify grossly • Aggressive surgery recommended • Tumor recurrence common • Median survival • Brachial plexus tumor – 12 months • Nerve roots – 5 months • If nerve root and vertebral canal involvement, poor outcome

  19. References • Inzana KD. Peripheral Nerve Disorders. In Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed (St. Louis, MO: Elsevier Saunders, 2005) pp. 896-7. • Kraft S, et al. MRI characteristics of peripheral nerve sheath tumors of the canine brachial plexus in 18 dogs. Vet Radiol Ultrasound 48(1):1-7;2007. • Platt SR, et al. MRI and ultrasonography in the diagnosis of a malignant peripheral nerve sheath tumor in a dog. Vet Radiol Ultrasound 40(4):367-71;1999. • Rose S, et al. Ultrasonographic evaluation of brachial plexus tumors in 5 dogs. Vet Radiol Ultrasound 46(6):514-7;2005 • Rudich SR, et al. CT of masses of the brachial plexus and contributing nerve roots in dogs. Vet Radiol Ultrasound 45(1):46-50;2004.

More Related